The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic characterization of STAS in stage 1 EGFR-mutated NSCLC and prognostic implications.
 
Stephanie Saw
Honoraria - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb/Celgene (Inst); Daiichi Sankyo/Astra Zeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Pfizer (Inst)
Speakers' Bureau - AstraZeneca (Inst); MSD Oncology (Inst)
Research Funding - AstraZeneca; Guardant Health
Travel, Accommodations, Expenses - AstraZeneca (Inst); Bristol-Myers Squibb/Celgene (Inst); MSD; MSD (Inst)
 
Mengyuan Pang
No Relationships to Disclose
 
Clare Patteri
No Relationships to Disclose
 
Angela Takano
No Relationships to Disclose
 
Ngak Leng Sim
No Relationships to Disclose
 
Jia Chi Yeo
No Relationships to Disclose
 
Gillianne Lai
Honoraria - AstraZeneca
Research Funding - AstraZeneca (Inst); Bristol-Myers-Squibb (Inst); Merck (Inst); Pfizer (Inst); Roche (Inst)
 
Darren Lim
No Relationships to Disclose
 
Ravindran Kanesvaran
Honoraria - Astellas Pharma; Bristol-Myers Squibb (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD Oncology (Inst); Novartis (Inst)
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Janssen Oncology (Inst); MSD Oncology; Novartis (Inst); pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; MSD Oncology
 
Mei-Kim Ang
No Relationships to Disclose
 
Quan Sing Ng
Research Funding - Bayer (Inst); BMS (Inst)
 
Amit Jain
No Relationships to Disclose
 
Wan Ling Tan
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Ipsen (Inst); MSD (Inst)
 
Aaron Tan
Honoraria - Amgen; AstraZeneca; Guardant Health AMEA; Janssen; Juniper Biologics; Pfizer; Roche; Thermo Fisher Scientific
Consulting or Advisory Role - Amgen; Amgen; Bayer; Pfizer
Research Funding - AstraZeneca (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - ASLAN Pharmaceuticals; Illumina
 
Wei Chong Tan
No Relationships to Disclose
 
Amanda Seet
No Relationships to Disclose
 
Boon-Hean Ong
Honoraria - AstraZeneca; Bristol-Myers Squibb Singapore; Johnson & Johnson; Medtronic; MSD; Roche; Stryker
Travel, Accommodations, Expenses - Bronchus; Johnson & Johnson; Medtronic; MSD; Stryker; Trans Med
 
Tony Kiat Hon Lim
No Relationships to Disclose
 
Anders Skanderup
No Relationships to Disclose
 
Daniel Tan
Honoraria - Novartis (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); DKSH (Inst); Genmab; Merck (Inst); Pfizer (Inst); Roche (Inst); Zymeworks
Research Funding - ACM Biolabs (Inst); AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer; Roche